| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A case-case analysis of women with breast cancer: predictors of interval vs screen-detected cancer
|
Dreher, Nickolas
|
|
|
191 |
3 |
p. 623-629
|
artikel
|
| 2 |
An overview of genetic services delivery for hereditary breast cancer
|
Reid, Sonya
|
|
|
191 |
3 |
p. 491-500
|
artikel
|
| 3 |
A tool to predict disparities in the timeliness of surgical treatment for breast cancer patients in the USA
|
Verdone, Christopher G.
|
|
|
191 |
3 |
p. 513-522
|
artikel
|
| 4 |
A triple-negative breast cancer surrogate subtype classification that correlates with gene expression subtypes
|
Yoo, Tae-Kyung
|
|
|
191 |
3 |
p. 599-610
|
artikel
|
| 5 |
Average duration of prior treatment lines predicts clinical benefit to eribulin chemotherapy in patients with metastatic breast cancer
|
Coe, Faye
|
|
|
191 |
3 |
p. 535-543
|
artikel
|
| 6 |
Breast cancer vaccines for treatment and prevention
|
Disis, Mary L.
|
|
|
191 |
3 |
p. 481-489
|
artikel
|
| 7 |
Care in the time of COVID-19: impact on the diagnosis and treatment of breast cancer in a large, integrated health care system
|
Tang, Annie
|
|
|
191 |
3 |
p. 665-675
|
artikel
|
| 8 |
Circulating lipids and breast cancer prognosis in the Malmö diet and cancer study
|
Harborg, Sixten
|
|
|
191 |
3 |
p. 611-621
|
artikel
|
| 9 |
Does conventional specimen radiography after neoadjuvant chemotherapy of breast cancer help to reduce the rate of second surgeries?
|
Schaefgen, Benedikt
|
|
|
191 |
3 |
p. 589-598
|
artikel
|
| 10 |
Enrollment of older metastatic breast cancer patients in first-line clinical trials: 9-year experience of the large-scale real-life multicenter French ESME cohort
|
Bringuier, M.
|
|
|
191 |
3 |
p. 577-587
|
artikel
|
| 11 |
Factors related to patient-reported cosmetic outcome after breast-conserving therapy for breast cancer
|
Brands-Appeldoorn, A. T. P. M.
|
|
|
191 |
3 |
p. 545-552
|
artikel
|
| 12 |
Impact of rapid genetic testing for BRCA1 and BRCA2 at time of breast cancer diagnosis on psychosocial functioning
|
Metcalfe, Kelly A.
|
|
|
191 |
3 |
p. 631-641
|
artikel
|
| 13 |
Impact of the EndoPredict genomic assay on treatment decisions for oestrogen receptor-positive early breast cancer patients: benefits of physician selective testing
|
Dinh, Phuong
|
|
|
191 |
3 |
p. 501-511
|
artikel
|
| 14 |
Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer: primary results from cohort B of the IPATunity130 randomized phase 3 trial
|
Turner, Nicholas
|
|
|
191 |
3 |
p. 565-576
|
artikel
|
| 15 |
Neighborhood characteristics and breast tumor methylation: using epigenomics to explore cancer outcome disparities
|
Gohar, Jazib
|
|
|
191 |
3 |
p. 653-663
|
artikel
|
| 16 |
Predicting the clinical outcomes and benefit from letrozole after 5 years of treatment with aromatase inhibitors for early breast cancer: analysis from CCTG MA.17R
|
Li, Yapeng
|
|
|
191 |
3 |
p. 523-533
|
artikel
|
| 17 |
Safety of systemic hormone replacement therapy in breast cancer survivors
|
Bluming, Avrum Z.
|
|
|
191 |
3 |
p. 685-686
|
artikel
|
| 18 |
Studying the association between breast cancer and renal cell carcinoma
|
Jazieh, Khalid
|
|
|
191 |
3 |
p. 643-652
|
artikel
|
| 19 |
The impact of the COVID-19 pandemic on perceived access to health care and preferences for health care provision in individuals (being) treated for breast cancer
|
Mink van der Molen, Dieuwke R.
|
|
|
191 |
3 |
p. 553-564
|
artikel
|
| 20 |
Yield of flow cytometry in addition to cytology for lymph node sampling in patients with incidental axillary adenopathy without a concurrent diagnosis of primary breast malignancy
|
Lo Gullo, Roberto
|
|
|
191 |
3 |
p. 677-683
|
artikel
|
Tijdschrift beschrijving